NEUMORA THERAPEUTICS INC
NMRA · NASDAQ
Updated at 2026-10-13 15:12:17
- Today's High
- $0.44
- Today’s Low
- $0.40
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $0.48
- Previous Close
- $0.43
- Volume
- 1.21M
- Market Cap
- $82.16M
- P/E Ratio
- --
- EPS
- $-1.23
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Pharmaceuticals
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- 260 ARSENAL PLACE, WATERTOWN, MA, UNITED STATES, 02472
- Country
- US
- Listing Date
- 2023-09-15
- Fiscal Year End
- December
- Shares Outstanding
- 185.28M
- CIK
- 0001885522
- Website
- neumoratx.com
Neumora Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutic treatments for brain diseases, neuropsychiatric disorders, and neurodegenerative diseases. The company is headquartered in Watertown, Massachusetts.
Financial Metrics
Revenue
2026-06-30
$0
2026-03-31
$0
2025-12-31
$0
2025-09-30
$0
Operating Expenses
2026-06-30
$42.19M
2026-03-31
$52.86M
2025-12-31
$58.48M
2025-09-30
$52.7M
Net Income
2026-06-30
-$43.08M
2026-03-31
-$53.45M
2025-12-31
-$59.45M
2025-09-30
-$56.75M
Net Profit Margin
2026-06-30
--
2026-03-31
--
2025-12-31
--
2025-09-30
--
Earnings Per Share
2026-06-30
$-0.23
2026-03-31
$-0.30
2025-12-31
$-0.35
2025-09-30
$-0.35
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$42.17M
2026-03-31
-$51.56M
2025-12-31
-$57.4M
2025-09-30
-$55.98M
Effective Tax Rate
2026-06-30
--
2026-03-31
-0.05%
2025-12-31
--
2025-09-30
--
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Operating Expenses | $42.19M | $52.86M | $58.48M | $52.7M |
| Net Income | -$43.08M | -$53.45M | -$59.45M | -$56.75M |
| Net Profit Margin | -- | -- | -- | -- |
| Earnings Per Share | $-0.23 | $-0.30 | $-0.35 | $-0.35 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$42.17M | -$51.56M | -$57.4M | -$55.98M |
| Effective Tax Rate | -- | -0.05% | -- | -- |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.